BiotechMX

Biotech de México con aprobación COFEPRIS de 36 meses mientras IMSS requería historial de 5 años y BIRMEX tenía mandato exclusivo para la producción de vacunas

Declive de años antes del cierre final · Error fatal: Mexico biotech: COFEPRIS (health regulator) clinical trial approval took 36+ months for novel biologics. IMSS (45M insured) procurement required 5-year local track record. ISSSTE had separate procurement process. BIRMEX (government biologics manufacturer) had exclusive vaccine production mandate. PISA and Liomont (Mexican pharma) had COFEPRIS relationships from 30+ years. Independent biotech had 36-month regulatory path before any revenue.